Parabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosedGC
General Catalyst
Activity from announced rounds
Activity in this selectionimc-456dc02f
- Rounds participated in
- 91
- Confirmed lead rounds
- 7 76 roles undisclosed
- New companies
- 89 First participation on record · 2 follow-on
- Funding in participating rounds
- $15.2B 86 disclosed · full round size, not this investor’s share
By stage
2 more
Pre-seed3
Growth2
By primary sector
14 more
Biotech5
Media & gaming4
Cybersecurity3
Developer tools3
Consumer2
Industrial tech2
Climate tech1
Edtech1
Foodtech1
Hardware1
Logistics1
Mobility1
Robotics1
Space tech1
By country
7 more
India3
France2
Canada1
Denmark1
Netherlands1
Spain1
Turkey1